Sector valuations Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
07:00:02 10/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 301.79 USD | +1.27% |
|
+4.00% | +51.29% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 73.13x | 4.68x | -0.3x | 4.21x | 16.18x | 20.08x | -.--% | 14.41B | ||
| 20.5x | 4.83x | 1.24x | 7.3x | 14.66x | 16.31x | 1.45% | 70.61B | ||
| 27.46x | 5.25x | 0.53x | 7.51x | 23.56x | 23.96x | 0.05% | 51.01B | ||
| 33.37x | 4.48x | 1.24x | 6x | 17.96x | 25.15x | 0.97% | 48.1B | ||
| 33.47x | 6.22x | -34.55x | 3.25x | 14.03x | 20.7x | -.--% | 42.78B | ||
| -19.64x | 20.57x | -0.31x | 203.45x | -20.92x | -19.93x | -.--% | 40.67B | ||
| 46.95x | 7.58x | 0.24x | 5.34x | 29.33x | 33.69x | -.--% | 40.3B | ||
| 27.18x | 2.18x | 0.56x | 7.73x | 20.09x | 23.49x | 0.42% | 30.59B | ||
| 32.53x | 3.41x | 1.49x | 6.94x | 18.03x | 21.62x | -.--% | 28.16B | ||
| -14.69x | 1.24x | -0.58x | 5.97x | -7.21x | -5.73x | -.--% | 24.36B | ||
| -60.75x | 32.31x | 0.82x | 11.86x | -60.25x | -67.7x | -.--% | 21.97B | ||
| 30.05x | 3.58x | -1.86x | 5.6x | 18.75x | 21.19x | -.--% | 21.89B | ||
| 34.8x | 25.94x | 2.31x | 5.72x | 25.98x | 27.18x | -.--% | 17.08B | ||
| 44.22x | 10.83x | 0.37x | 16.41x | 33.73x | 36.24x | 0.33% | 15.49B | ||
| 25.71x | 2.83x | 0.75x | 2.23x | 9.6x | 14.86x | 1.04% | 14.99B | ||
| 18.52x | 5.7x | 1.14x | 5.52x | 12.91x | 13.67x | -.--% | 14.83B | ||
| -15.24x | 52.54x | 0.84x | 3461.77x | -17.74x | -15.1x | -.--% | 14.07B | ||
| 967.07x | 15.69x | -7.78x | 33.64x | 581.04x | -217.65x | -.--% | 13.54B | ||
| -351.75x | 9.36x | 4.48x | 17.7x | 1654.23x | -320.61x | -.--% | 12.81B | ||
| Average | 50.15x | 11.54x | -1.55x | 200.95x | 125.47x | -18.35x | 0.22% | 28.3B | |
| Weighted average by Cap. | 35.45x | 9.47x | -2.33x | 112.87x | 63.99x | -0.64x | 0.34% |
Select your edition
All financial news and data tailored to specific country editions
















